Democratizing CRISPR? Legal complexity, access and the right to science

Key Points

• Legal complexity affects access to CRISPR technology, impacting public participation.
• Access to CRISPR remains challenging due to intellectual property laws and regulations.
• This analysis discusses the right to science as it relates to emerging biotechnologies.
• Implications suggest a need for policy reforms to democratize access to scientific advancements.